
  
    
      
        
        Grant_NNP [_NN 1_CD ]_NN describes_VBZ as_IN incorrect_JJ the_DT statement_NN that_IN at_IN least_JJS half_NN of_IN the_DT explanation_NN for_IN
        individual_JJ differences_NNS in_IN risk_NN for_IN Alzheimer_NNP disease_NN is_VBZ genetic_JJ ._. He_PRP suggests_VBZ instead_RB that_IN
        dietary_JJ and_CC lifestyle_NN factors_NNS explain_VBP the_DT majority_NN of_IN individual_JJ susceptibility_NN to_TO
        Alzheimer_NNP disease_NN ._.
        The_DT basis_NN for_IN asserting_VBG a_DT 50_CD %_NN or_CC greater_JJR role_NN for_IN genetics_NNS in_IN Alzheimer_NNP disease_NN risk_NN
        comes_VBZ from_IN family_NN studies_NNS and_CC from_IN twin_JJ studies_NNS ._. In_IN family_NN studies_NNS ,_, first-degree_JJ relatives_NNS
        of_IN individuals_NNS with_IN Alzheimer_NNP disease_NN are_VBP at_IN more_RBR than_IN double_VB the_DT risk_NN of_IN Alzheimer_NNP disease_NN
        compared_VBN to_TO those_DT with_IN no_DT affected_VBN relatives_NNS [_NN 2_CD ,_, 3_CD ]_NN ._. In_IN twin_JJ studies_NNS ,_, across_IN different_JJ
        Scandinavian_JJ twin_JJ registries_NNS ,_, estimates_NNS of_IN heritability_NN of_IN Alzheimer_NNP disease_NN range_NN from_IN 55_CD %_NN
        to_TO over_IN 70_CD %_NN [_NN 4_CD ]_NN ._.
        Genetic_JJ risk_NN undoubtedly_RB represents_VBZ the_DT cumulative_JJ influence_NN of_IN many_JJ genes_NNS ,_, including_VBG
        apolipoprotein_NN E_NNP (_( APOE_NNP )_) and_CC other_JJ genes_NNS not_RB yet_RB identified_VBN ._. In_IN particular_JJ ,_, it_PRP appears_VBZ that_IN
        the_DT magnitude_NN of_IN the_DT genetic_JJ component_NN of_IN Alzheimer_NNP disease_NN risk_NN is_VBZ similar_JJ across_IN ethnic_JJ
        communities_NNS ,_, but_CC that_IN different_JJ genetic_JJ factors_NNS may_MD contribute_VB differently_RB to_TO that_DT risk_NN in_IN
        white_JJ ,_, Latino_NNP ,_, and_CC African_NNP American_JJ families_NNS [_NN 5_CD ]_NN ._.
        Further_RB ,_, there_EX are_VBP interactions_NNS between_IN genetic_JJ and_CC environmental_JJ risks_NNS ,_, for_IN example_NN ,_,
        between_IN the_DT APOE_NNP e_SYM 4_CD allele_NN and_CC high_JJ cholesterol_NN [_NN 6_CD ]_NN or_CC head_NN injury_NN [_NN 7_CD ]_NN ._.
        Clearly_RB Alzheimer_NNP disease_NN is_VBZ the_DT outcome_NN of_IN multiple_JJ genetic_JJ and_CC multiple_JJ environmental_JJ
        influences_NNS ,_, operating_VBG additively_RB and_CC interactively_RB ._. If_IN genetic_JJ effects_NNS account_VBP for_IN half_NN of_IN
        individual_JJ differences_NNS in_IN liability_NN ,_, then_RB environmental_JJ influences_VBZ also_RB account_NN for_IN half_NN of_IN
        the_DT variation_NN in_IN susceptibility_NN ._. From_IN a_DT public_JJ health_NN viewpoint_NN ,_, it_PRP is_VBZ vital_JJ to_TO identify_VB
        those_DT influences_VBZ that_WDT are_VBP modifiable_JJ ._. Controlling_NNP blood_NN pressure_NN and_CC avoiding_VBG head_NN trauma_NN
        are_VBP examples_NNS ._. However_RB ,_, it_PRP is_VBZ also_RB important_JJ to_TO appreciate_VB that_IN individuals_NNS bring_VBP
        differences_NNS in_IN genetic_JJ risk_NN to_TO the_DT table_NN ._.
      
    
  
